JP2005530732A5 - - Google Patents

Download PDF

Info

Publication number
JP2005530732A5
JP2005530732A5 JP2003584094A JP2003584094A JP2005530732A5 JP 2005530732 A5 JP2005530732 A5 JP 2005530732A5 JP 2003584094 A JP2003584094 A JP 2003584094A JP 2003584094 A JP2003584094 A JP 2003584094A JP 2005530732 A5 JP2005530732 A5 JP 2005530732A5
Authority
JP
Japan
Prior art keywords
glp
pharmaceutical composition
composition according
compound
derivative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003584094A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005530732A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2003/008457 external-priority patent/WO2003087139A2/en
Publication of JP2005530732A publication Critical patent/JP2005530732A/ja
Publication of JP2005530732A5 publication Critical patent/JP2005530732A5/ja
Pending legal-status Critical Current

Links

JP2003584094A 2002-04-10 2003-03-27 胃不全麻痺の治療 Pending JP2005530732A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US37165002P 2002-04-10 2002-04-10
PCT/US2003/008457 WO2003087139A2 (en) 2002-04-10 2003-03-27 Treatment of gastroparesis

Publications (2)

Publication Number Publication Date
JP2005530732A JP2005530732A (ja) 2005-10-13
JP2005530732A5 true JP2005530732A5 (https=) 2006-05-18

Family

ID=29250714

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003584094A Pending JP2005530732A (ja) 2002-04-10 2003-03-27 胃不全麻痺の治療

Country Status (18)

Country Link
US (1) US20050164925A1 (https=)
EP (1) EP1496924A4 (https=)
JP (1) JP2005530732A (https=)
KR (1) KR20040098063A (https=)
CN (1) CN1735423A (https=)
AU (1) AU2003220403A1 (https=)
BR (1) BR0308904A (https=)
CA (1) CA2480858A1 (https=)
EA (1) EA200401345A1 (https=)
EC (1) ECSP045345A (https=)
HR (1) HRP20040939A2 (https=)
IL (1) IL164266A0 (https=)
MX (1) MXPA04009929A (https=)
NO (1) NO20044815L (https=)
NZ (1) NZ535684A (https=)
PL (1) PL373658A1 (https=)
WO (1) WO2003087139A2 (https=)
ZA (1) ZA200408111B (https=)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8666495B2 (en) 1999-03-05 2014-03-04 Metacure Limited Gastrointestinal methods and apparatus for use in treating disorders and controlling blood sugar
US9101765B2 (en) 1999-03-05 2015-08-11 Metacure Limited Non-immediate effects of therapy
US8792985B2 (en) 2003-07-21 2014-07-29 Metacure Limited Gastrointestinal methods and apparatus for use in treating disorders and controlling blood sugar
KR101241862B1 (ko) * 2003-09-19 2013-03-13 노보 노르디스크 에이/에스 신규 glp-1 유도체
JP2007537981A (ja) * 2003-09-19 2007-12-27 ノボ ノルディスク アクティーゼルスカブ 新規の血漿タンパク質親和性タグ
EP1793891B1 (en) 2004-08-18 2011-11-09 Metacure Limited Monitoring, analysis, and regulation of eating habits
US9821158B2 (en) 2005-02-17 2017-11-21 Metacure Limited Non-immediate effects of therapy
WO2006087712A2 (en) 2005-02-17 2006-08-24 Metacure N.V. Charger with data transfer capabilities
TWI372629B (en) 2005-03-18 2012-09-21 Novo Nordisk As Acylated glp-1 compounds
JP5755398B2 (ja) 2005-03-18 2015-07-29 ノヴォ ノルディスク アー/エス 伸長されたglp−1化合物
US8265758B2 (en) * 2005-03-24 2012-09-11 Metacure Limited Wireless leads for gastrointestinal tract applications
WO2007080595A2 (en) 2006-01-12 2007-07-19 Metacure N.V. Electrode assemblies, tools, and methods for gastric wall implantation
WO2006129321A2 (en) 2005-06-02 2006-12-07 Metacure N.V. Gi lead implantation
US8442841B2 (en) * 2005-10-20 2013-05-14 Matacure N.V. Patient selection method for assisting weight loss
US8295932B2 (en) 2005-12-05 2012-10-23 Metacure Limited Ingestible capsule for appetite regulation
ES2495741T3 (es) * 2006-04-20 2014-09-17 Amgen, Inc Compuestos de GLP-1
AU2012203915B9 (en) * 2006-04-20 2014-10-09 Amgen Inc. GLP-1 compounds
US8417329B2 (en) * 2007-05-09 2013-04-09 Metacure Ltd. Analysis and regulation of food intake
US8423130B2 (en) * 2008-05-09 2013-04-16 Metacure Limited Optimization of thresholds for eating detection
KR20110039348A (ko) 2008-08-06 2011-04-15 노보 노르디스크 헬스 케어 악티엔게젤샤프트 연장된 생체내 효능을 가지는 콘쥬게이트된 단백질
JP5816097B2 (ja) 2009-01-22 2015-11-18 ノヴォ・ノルディスク・ヘルス・ケア・アーゲー 安定な成長ホルモン化合物
JP6086528B2 (ja) 2009-08-06 2017-03-01 ノヴォ・ノルディスク・ヘルス・ケア・アーゲー 長期のインビボ有効性を有する成長ホルモン
EP2482840A4 (en) * 2009-08-07 2013-06-26 Mannkind Corp VAL (8) GLP-1 COMPOSITION AND METHOD FOR THE TREATMENT OF REAGENTS AND / OR IRRITATION SYNDROME
CN118767117A (zh) 2010-01-22 2024-10-15 诺沃—诺迪斯克保健股份有限公司 体内功效延长的生长激素
JP5980689B2 (ja) 2010-01-22 2016-08-31 ノヴォ・ノルディスク・ヘルス・ケア・アーゲー 安定な成長ホルモン化合物
US8934975B2 (en) 2010-02-01 2015-01-13 Metacure Limited Gastrointestinal electrical therapy
WO2011136361A1 (ja) 2010-04-30 2011-11-03 株式会社 三和化学研究所 生理活性物質等の生体内安定性向上のためのペプチド及び生体内安定性が向上した生理活性物質
UA116217C2 (uk) 2012-10-09 2018-02-26 Санофі Пептидна сполука як подвійний агоніст рецепторів glp1-1 та глюкагону
HK1211232A1 (en) 2012-12-21 2016-05-20 Sanofi Exendin-4 derivatives as dual glp1/gip or trigonal glp1/gip/glucagon agonists
US11045523B2 (en) 2013-04-05 2021-06-29 Novo Nordisk Healthcare Ag Formulation of growth hormone albumin-binder conjugate

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6268343B1 (en) * 1996-08-30 2001-07-31 Novo Nordisk A/S Derivatives of GLP-1 analogs
US5981488A (en) * 1997-03-31 1999-11-09 Eli Lillly And Company Glucagon-like peptide-1 analogs
IL142707A0 (en) * 2000-04-27 2002-03-10 Pfizer Prod Inc Methods of treating obesity using a neurotensin receptor ligand

Similar Documents

Publication Publication Date Title
JP2005530732A5 (https=)
US20240376175A1 (en) Novel GLP-1 Analogues
KR102906485B1 (ko) 변형된 gip 펩티드 유사체
JP2007001987A5 (https=)
ES2444622T3 (es) Derivado peptídico insulinotrópico en el que se ha modificado su aminoácido N-terminal
CN102711804B (zh) 包含glp-1激动剂和甲硫氨酸的药物组合物
JP2002526454A5 (https=)
JP2007523881A5 (https=)
PT1143989E (pt) Exendinas para supressão de glucagon
CN108271356A (zh) 肠降血糖素-胰岛素缀合物
RU2007134156A (ru) Ацилированные glp-1 соединения
TWI353250B (en) Glp-1 pharmaceutical compositions
US20180280480A1 (en) Compositions and peptides having dual glp-1r and glp-2r agonist activity
JP2018500291A (ja) 制御放出および持続的放出のためのelp融合タンパク質
AU2022222674A9 (en) Glucagon-like peptide-1 receptor antagonists
WO2015180634A1 (zh) 用于治疗2型糖尿病的长效肠激素多肽类似物及应用
US20240058422A1 (en) Glucagon-like peptide-1 receptor antagonists
HK40117578A (zh) 胰高血糖素样肽-1受体拮抗剂
RU2008129731A (ru) Новые пептиды-т-хелперные антигенные детерминанты (thd)
HK1207088B (zh) N-末端氨基酸经修饰的促胰岛素释放肽衍生物